Shelli Kesler, PhD
Associate Professor of Neuro-oncology
Director, Cognitive Neuroimaging Lab
University of Texas MD Anderson Cancer Center
Dr. Kesler’s training is in neuropsychology, cognitive neuroscience and applied statistics. She is currently an Associate Professor of Neuro-oncology at the University of Texas MD Anderson Cancer Center. Dr. Kesler is particularly interested in the neurotoxic effects of cancer therapies. She has pioneered the application of advanced neuroscience methods including connectomics and machine learning to the characterization of chemotherapy-related brain injury wth the aim of identifying diagnostic and prognostic biomarkers. She investigates these biomarkers in both humans and animals with the goal of identifying targets for intervention. Dr. Kesler has authored over 70 scientific publications and was a previous recipient of the NIH Director’s New Innovator Award.